Tecartus 0.4 – 2 × 108 cells dispersion for infusion
- Licence status
- Active substances
- Autologous Peripheral Blood T Cells CD4 and CD8 selected and CD3 and CD28 Activated Transduced with Retroviral Vectir Expressing Anti CD19 CD28/CD3-Zeta Chimeric Antigen Receptor and Cultured
- Dosage Form
- Dispersion for infusion
- Licence number
- EU/1/20/1492/001
- Licence holder
- Kite Pharma EU B.V.
Product documents
Licence information
- ATC code
- L01XL06 brexucabtagene autoleucel
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 14/12/2020